unknown
Stage
1
Investors
About
CARMAT designs and develops an advanced artificial heart intended as a therapeutic alternative for patients with advanced biventricular heart failure. The company develops implantable cardiac devices to support or replace heart function.
Explore CARMAT's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.